Want to see JP:9820 full AI Analyst Report?

MT Genex Corporation (9820) Price & Analysis

0 Followers

9820 Stock Chart & Stats

¥3500.00

-¥45.00(-1.75%)

At close: Jan 08 4:00 PM EST

¥3500.00

-¥45.00(-1.75%)

Day’s Range― - ―

52-Week Range¥3,210.00 - ¥4,290.00

Previous CloseN/A

Volume300.00

Average Volume (3M)806.00

Market Cap

¥4.05B

Enterprise Value¥337.06

Total Cash (Recent Filing)¥3.56B

Total Debt (Recent Filing)¥77.74M

Price to Earnings (P/E)9.2

Beta0.10

Next Earnings

Nov 06, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield1.08%

Share Statistics

EPS (TTM)406.28

Shares Outstanding1,079,600

10 Day Avg. Volume640

30 Day Avg. Volume806

Financial Highlights & Ratios

PEG Ratio0.64

Price to Book (P/B)0.85

Price to Sales (P/S)0.80

P/FCF Ratio68.41

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue GrowthAccelerating revenue indicates sustained demand and expanding business activity. If maintained, this growth can support operating scale, strengthen market position and provide a foundation for continued earnings development over the next several quarters.

Conservative Balance SheetMinimal leverage reduces interest burden and refinancing risk, giving the company resilience through weaker cycles. The conservative balance sheet also preserves flexibility to fund operations, assets or growth without relying heavily on external debt.

Stable ProfitabilityMaintaining a positive and fairly consistent net margin while revenue grows demonstrates an established ability to convert sales into profit. This supports internal funding capacity and provides a durable earnings base despite cost and mix pressures.

Bears Say

Weak Cash ConversionVery low operating cash conversion means reported earnings are not consistently translating into cash. Working-capital drag or related pressure could constrain self-funded investment and reduce confidence in the durability and quality of near-term earnings.

Margin CompressionFalling operating and EBITDA margins suggest that cost pressure or an unfavorable business mix is absorbing part of the benefit from revenue growth. Persistent compression could limit earnings scalability and weaken long-term operating leverage.

Moderate Capital ReturnsA strong balance sheet does not yet translate into highly productive returns on shareholder capital. Moderate ROE may indicate limited capital efficiency, which could constrain profit growth relative to the company’s equity base over time.

9820 FAQ

What was MT Genex Corporation’s price range in the past 12 months?

MT Genex Corporation lowest stock price was ¥3210.00 and its highest was ¥4290.00 in the past 12 months.

What is MT Genex Corporation’s market cap?

MT Genex Corporation’s market cap is ¥4.05B.

When is MT Genex Corporation’s upcoming earnings report date?

MT Genex Corporation’s upcoming earnings report date is Nov 06, 2026 which is in 51 days.

How were MT Genex Corporation’s earnings last quarter?

MT Genex Corporation released its earnings results on Aug 07, 2026. The company reported ¥151.91 earnings per share for the quarter.

Is MT Genex Corporation overvalued?

According to Wall Street analysts MT Genex Corporation’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does MT Genex Corporation pay dividends?

MT Genex Corporation pays a Annually dividend of ¥40 which represents an annual dividend yield of 1.08%. See more information on MT Genex Corporation dividends here

What is MT Genex Corporation’s EPS estimate?

MT Genex Corporation’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does MT Genex Corporation have?

MT Genex Corporation has 1,079,600 shares outstanding.

What happened to MT Genex Corporation’s price movement after its last earnings report?

MT Genex Corporation reported an EPS of ¥151.91 in its last earnings report. Following the earnings report the stock price went down -0.134%.

Which hedge fund is a major shareholder of MT Genex Corporation?

Currently, no hedge funds are holding shares in JP:9820

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

MT Genex Corporation

MT Genex Corporation, along with its group of companies, serves as a specialist contractor for both new construction and refurbishment of homes and commercial premises throughout Japan. Its activities are structured across four primary divisions: Renovation Services, Parking Solutions, Facilities Upkeep & Management, and Insurance Brokering. The firm executes both interior and exterior building and property enhancement projects, offering comprehensive design and oversight for real estate developments. Additionally, it is responsible for the operation, administration, and leasing of parking areas, as well as the general management of real estate holdings. MT Genex also devises and proposes risk management strategies, encompassing a variety of non-life insurance offerings. Further expanding its portfolio, the company is engaged in real estate development, hotel operations, and the maintenance of electrical systems. Established in Tokyo, Japan, in 1945, MT Genex Corporation functions as a subsidiary of Mori Trust Co., Ltd.